# Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects

> **NCT04542252** · PHASE1 · COMPLETED · sponsor: **SymBio Pharmaceuticals** · enrollment: 13 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** SyB V-1901
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT04542252
- **Lead sponsor:** SymBio Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-09
- **Primary completion:** 2020-12-22
- **Final completion:** 2021-01-29
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542252, "Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04542252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*